PALANTIR TECHNOLOGIES INC-A (PLTR)

US69608A1088 - Common Stock

21.3701  +0.06 (+0.28%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to PLTR. PLTR was compared to 275 industry peers in the Software industry. PLTR is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. PLTR is valued quite expensive, but it does show an excellent growth. With these ratings, PLTR could be worth investigating further for growth investing!.



5

1. Profitability

1.1 Basic Checks

PLTR had positive earnings in the past year.
In the past year PLTR had a positive cash flow from operations.
PLTR had negative earnings in 4 of the past 5 years.
In multiple years PLTR reported negative operating cash flow during the last 5 years.

1.2 Ratios

PLTR's Return On Assets of 4.64% is amongst the best of the industry. PLTR outperforms 80.36% of its industry peers.
PLTR has a Return On Equity of 6.04%. This is in the better half of the industry: PLTR outperforms 77.82% of its industry peers.
PLTR has a better Return On Invested Capital (2.51%) than 74.18% of its industry peers.
Industry RankSector Rank
ROA 4.64%
ROE 6.04%
ROIC 2.51%
ROA(3y)-7.39%
ROA(5y)-20.53%
ROE(3y)-10.42%
ROE(5y)-101.87%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

PLTR has a Profit Margin of 9.43%. This is amongst the best in the industry. PLTR outperforms 81.09% of its industry peers.
PLTR has a Operating Margin of 5.39%. This is in the better half of the industry: PLTR outperforms 74.91% of its industry peers.
The Gross Margin of PLTR (80.62%) is better than 84.00% of its industry peers.
PLTR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.39%
PM (TTM) 9.43%
GM 80.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.98%
GM growth 5Y2.23%

8

2. Health

2.1 Basic Checks

PLTR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for PLTR has been increased compared to 1 year ago.
The number of shares outstanding for PLTR has been increased compared to 5 years ago.
PLTR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 26.74 indicates that PLTR is not in any danger for bankruptcy at the moment.
PLTR has a Altman-Z score of 26.74. This is amongst the best in the industry. PLTR outperforms 98.18% of its industry peers.
There is no outstanding debt for PLTR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 26.74
ROIC/WACC0.25
WACC9.92%

2.3 Liquidity

PLTR has a Current Ratio of 5.55. This indicates that PLTR is financially healthy and has no problem in meeting its short term obligations.
PLTR has a Current ratio of 5.55. This is amongst the best in the industry. PLTR outperforms 90.55% of its industry peers.
PLTR has a Quick Ratio of 5.55. This indicates that PLTR is financially healthy and has no problem in meeting its short term obligations.
PLTR has a Quick ratio of 5.55. This is amongst the best in the industry. PLTR outperforms 90.55% of its industry peers.
Industry RankSector Rank
Current Ratio 5.55
Quick Ratio 5.55

8

3. Growth

3.1 Past

PLTR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 316.67%, which is quite impressive.
The Revenue has grown by 16.75% in the past year. This is quite good.
Measured over the past years, PLTR shows a very strong growth in Revenue. The Revenue has been growing by 30.17% on average per year.
EPS 1Y (TTM)316.67%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q100%
Revenue 1Y (TTM)16.75%
Revenue growth 3Y26.75%
Revenue growth 5Y30.17%
Revenue growth Q2Q19.61%

3.2 Future

PLTR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.01% yearly.
The Revenue is expected to grow by 23.50% on average over the next years. This is a very strong growth
EPS Next Y36.81%
EPS Next 2Y27.06%
EPS Next 3Y24.44%
EPS Next 5Y27.01%
Revenue Next Year22.26%
Revenue Next 2Y20.57%
Revenue Next 3Y20.69%
Revenue Next 5Y23.5%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

2

4. Valuation

4.1 Price/Earnings Ratio

PLTR is valuated quite expensively with a Price/Earnings ratio of 85.48.
PLTR's Price/Earnings ratio is in line with the industry average.
PLTR is valuated expensively when we compare the Price/Earnings ratio to 24.83, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 62.48 indicates a quite expensive valuation of PLTR.
PLTR's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of PLTR to the average of the S&P500 Index (21.32), we can say PLTR is valued expensively.
Industry RankSector Rank
PE 85.48
Fwd PE 62.48

4.2 Price Multiples

60.36% of the companies in the same industry are more expensive than PLTR, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as PLTR.
Industry RankSector Rank
P/FCF 67.81
EV/EBITDA 264.85

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PLTR does not grow enough to justify the current Price/Earnings ratio.
PLTR's earnings are expected to grow with 24.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.32
PEG (5Y)N/A
EPS Next 2Y27.06%
EPS Next 3Y24.44%

0

5. Dividend

5.1 Amount

PLTR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PALANTIR TECHNOLOGIES INC-A

NYSE:PLTR (4/18/2024, 10:33:10 AM)

21.3701

+0.06 (+0.28%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap47.26B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 85.48
Fwd PE 62.48
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)2.32
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.64%
ROE 6.04%
ROCE
ROIC
ROICexc
ROICexgc
OM 5.39%
PM (TTM) 9.43%
GM 80.62%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 5.55
Quick Ratio 5.55
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)316.67%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y36.81%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)16.75%
Revenue growth 3Y26.75%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y